The global continuous glucose monitoring systems market size was valued at USD 7.04 Billion in 2024. Looking forward, the market is forecast to reach USD 10.92 Billion by 2033, exhibiting a CAGR of 4.75% from 2025-2033. North America currently dominates the market, holding a market share of over 38.7% in 2024. The increasing awareness and adoption of CGM devices, rising prevalence of diabetes, significant technological advancements in CGM devices, and ongoing shift towards preventive healthcare are some of the factors boosting the continuous glucose monitoring systems market share.
Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.
2. What is the future outlook of continuous glucose monitoring systems market?
3. What are the key factors driving the continuous glucose monitoring systems market?
4. Which region accounts for the largest continuous glucose monitoring systems market share?
5. Which are the leading companies in the global continuous glucose monitoring systems market?
Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.
Continuous Glucose Monitoring Systems Market Trends:
The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.Market Segmentation:
This report provides an analysis of the key trends in each segment of the global continuous glucose monitoring systems market, along with forecast at the global, regional, and country levels from 2025-2033. The market has been categorized based on the component, demographics, and end user.Breakup by Component:
- Sensors
- Transmitters and Receivers
- Integrated Insulin Pumps
Breakup by Demographics:
- Child Population (≤14 years)
- Adult Population (>14 years)
Breakup by End User:
- Clinics and Diagnostics Centers
- ICUs
- Home Healthcare
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.Key Questions Answered in This Report
1. How big is the continuous glucose monitoring systems market?2. What is the future outlook of continuous glucose monitoring systems market?
3. What are the key factors driving the continuous glucose monitoring systems market?
4. Which region accounts for the largest continuous glucose monitoring systems market share?
5. Which are the leading companies in the global continuous glucose monitoring systems market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Continuous Glucose Monitoring Systems Market
6 Market Breakup by Component
7 Market Breakup by Demographics
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- A. Menarini Diagnostics S.r.l.
- Abbott Laboratories
- DexCom Inc.
- F. Hoffmann-La Roche AG
- Glysens Incorporated
- LifeScan Inc. (Johnson & Johnson)
- Medtronic PLC
- Medtrum Technologies Inc.
- Nemaura Medical Inc.
- Novo Nordisk A/S
- Senseonics Holdings Inc.
- Waveform Technologies Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 143 |
Published | May 2025 |
Forecast Period | 2024 - 2033 |
Estimated Market Value ( USD | $ 7.04 Billion |
Forecasted Market Value ( USD | $ 10.92 Billion |
Compound Annual Growth Rate | 5.0% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |